切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2021, Vol. 17 ›› Issue (03) : 278 -283. doi: 10.3877/cma.j.issn.1673-5250.2021.03.007

论著

海南省苗族新生儿葡萄糖-6-磷酸脱氢酶缺乏症发病情况及基因特征分析
石海杰1,1, 陈秋霞2,,2()   
  • 收稿日期:2020-10-10 修回日期:2021-04-28 出版日期:2021-06-01
  • 通信作者: 陈秋霞

Prevalence of glucose-6-phosphate dehydrogenase deficiency and characteristics of G6PD gene mutations of neonates of Miao Nationality in Hainan Province

Haijie Shi1,1, Qiuxia Chen2,2,()   

  • Received:2020-10-10 Revised:2021-04-28 Published:2021-06-01
  • Corresponding author: Qiuxia Chen
  • Supported by:
    Scientific Research Project of Hainan Health and Family Planning Commission(18A200167)
引用本文:

石海杰, 陈秋霞. 海南省苗族新生儿葡萄糖-6-磷酸脱氢酶缺乏症发病情况及基因特征分析[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(03): 278-283.

Haijie Shi, Qiuxia Chen. Prevalence of glucose-6-phosphate dehydrogenase deficiency and characteristics of G6PD gene mutations of neonates of Miao Nationality in Hainan Province[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2021, 17(03): 278-283.

目的

探讨海南省苗族新生儿葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症的发病情况及其G6PD基因突变特点。

方法

选择2017—2019年,于海南省接受G6PD缺乏症筛查的3 248例苗族新生儿为研究对象。采集其足跟血干血斑样本,采用荧光免疫分析法进行G6PD活性定量初筛;对G6PD活性<26 U/dL的初筛阳性苗族新生儿足跟血干血斑样本,采用聚合酶链反应(PCR)+导流杂交法,进行G6PD基因突变位点及其类型(纯合或杂合突变)分析。本研究经海南省妇幼保健院(现更名为:海南省妇女儿童医学中心)医学伦理委员会批准[审批文号:(2018)伦审第(35)号],并与所有受试儿监护人签署研究知情同意书。

结果

①这3 248例苗族新生儿的G6PD缺乏症初筛阳性率为7.1%(232/3 248),接受基因检测的232例新生儿中,G6PD缺乏症发病率为86.2%(200/232)。本组男性与女性新生儿的G6PD缺乏症初筛阳性率及发病率比较,差异均无统计学意义(均为P>0.05)。②对232例G6PD缺乏症初筛呈阳性苗族新生儿的G6PD基因检测结果显示,200例新生儿发生G6PD基因突变,包括共计209个突变位点的12种突变,分别为c.1376G>T(占比62.7%)、c.1388G>A(占比21.1%)、c.95A>G、c.1311C>T、c.871G>A、c.1024G>T、c.392G>T、c.1360C>T、c.517T>C、c.592C>T、c.487G>A和c.383T>C。

结论

海南省苗族人群G6PD缺乏症发病率较高,其G6PD基因突变以c.1376G>T及c.1388G>A为主。

Objective

To investigate prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency and characteristics of G6PD gene mutations of neonates of Miao Nationality in Hainan Province.

Methods

A total of 3 248 neonates of Miao Nationality who received G6PD deficiency screening in Hainan Province from January 2017 to December 2019 were selected as research objects. G6PD activity quantity analysis of dried heel blood spots samples of them were measured by fluorescence immunoassay method for G6PD deficiency screening. For positive samples of G6PD deficiency whose G6PD activity<26 U/dL, polymerase chain reaction (PCR) with flow-through hybridization method was used to analyze G6PD gene mutation sites and types (homozygous or heterozygous mutation). This study was approved by Ethical Review Board of Hainan Maternal and Child Health Hospital (now renamed as Hainan Women and Children′s Medical Center) [Approval No. (2018)35]. All neonatal guardians signed the informed consents.

Results

① Among 3 248 neonates of Miao Nationality, the screening positive rate of G6PD deficiency was 7.1%(232/ 3 248); among 232 neonates who received genetic testing, prevalence of G6PD deficiency was 86.2%(200/232). There were no significant differences in screening positive rate and prevalence of G6PD deficiency between male and female neonates (P>0.05 for both). ②G6PD gene detection results of 232 neonates with G6PD deficiency screening positive showed that 200 neonates had G6PD gene mutation, including 12 mutation types with 209 mutation sites, they were c. 1376G>T (accounted for 62.7%), c. 1388G>A (accounted for 21.1%), c. 95A>G, c. 1311C>T, c. 871G>A, c. 1024G>T, c. 392G>T, c. 1360C>T, c. 517T>C, c. 592C>T, c. 487G>A and c. 383T>C, respectively.

Conclusions

Miao Nationality population-based prevalence of G6PD deficiency is high in Hainan province, and their major mutations of G6PD gene are c. 1376G>T and c. 1388G>A.

表1 海南省200例苗族G6PD缺乏症新生儿G6PD基因突变及其构成比
图1 本组部分G6PD缺乏症新生儿G6PD基因检测杂交膜显色图及判读结果[图1A:1例患儿(No.20,男性)G6PD基因的c.1376G>T纯合突变(箭头所示);图1B:1例患儿(No.45,男性)G6PD基因的c.1311C>T纯合突变;图1C:1例患儿(No.17,男性)G6PD基因的c.1376G>T纯合突变复合c.1311C>T纯合突变;图1D:1例患儿(No.23,女性)G6PD基因的c.1376G>T杂合突变复合c.1311C>T杂合突变(箭头所示)]
[1]
Yen WC, Wu YH, Wu CC, et al. Impaired inflammasome activation and bacterial clearance in G6PD deficiency due to defective NOX/p38 MAPK/AP-1 redox signaling[J]. Redox Biol, 2020, 28: 101363. DOI: 10.1016/j.redox.2019.101363.
[2]
Nkhoma ET, Poole C, Vannappagari V, et al. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and Meta-analysis[J]. Blood Cells Mol Dis, 2009, 42(3): 267-278. DOI: 10.1016/j.bcmd.2008.12.005.
[3]
中华预防医学会出生缺陷预防与控制专业委员会新生儿筛查学组,中国医师协会医学遗传医师分会临床生化遗传专业委员会,中国医师协会青春期医学专业委员会临床遗传学组. 葡萄糖-6-磷酸脱氢酶缺乏症新生儿筛查、诊断和治疗专家共识[J]. 中华儿科杂志2017, 55(6): 411-414. DOI: 10.3760/cma.j.issn.0578-1310.2017.06.003.
[4]
Tseghereda YG, Nganga JK, Kimang′a AN, et al. Glucose-6-phosphate dehydrogenase deficiency allelic variants and their prevalence in malaria patients in Eritrea[J]. Pan Afr Med J, 2018, 31: 46. DOI: 10.11604/pamj.2018.31.46.16527.
[5]
赵振东,刘秀莲,窦倩如,等. 海南省新生儿G6PD缺乏症筛查十年回顾分析[J]. 中华检验医学杂志2020, 43(2): 171-174. DOI: 10.3760/cma.j.issn.1009-9158.2020.02.013.
[6]
卫生部. 新生儿疾病筛查血片采集技术规范[J]. 中国妇幼保健2005, 20(2): 132.
[7]
Harcke SJ, Rizzolo D, Harcke HT. G6PD deficiency: an update[J]. JAAPA, 2019, 32(11): 21-26. DOI: 10.1097/01.JAA.0000586304.65429.a7.
[8]
Gong ZH, Tian GL, Huang QW, et al. Reduced glutathione and glutathione disulfide in the blood of glucose-6-phosphate dehydrogenase-deficient newborns[J]. BMC Pediatr, 2017, 17(1): 172. DOI: 10.1186/s12887-017-0920-y.
[9]
刘秀莲,王洁,林燕,等. 346例海南黎族新生儿G6PD基因突变分析[J]. 基因组学与应用生物学2019, 38(9): 4224-4229. DOI: 10.13417/j.gab.038.004224.
[10]
陈开科,符菊秀,熊先会,等. 海南省澄迈县人群G6PD缺乏症基因突变分析[J]. 基础医学与临床2016, 36(9): 1222-1226.
[11]
刘秀莲,王洁,黄慈丹,等. 海口地区新生儿G6PD基因突变分析[J]. 分子诊断与治疗杂志2017, 9(3): 165-167,177. DOI: 10.3969/j.issn.1674-6929.2017.03.004.
[12]
庄晓珊. 为民办实事回访:海南新生儿遗传代谢病筛查率超98%[EB/OL]. (2018-01-12)[2020-10-05].

URL    
[13]
Hu R, Lin M, Ye J, et al. Molecular epidemiological investigation of G6PD deficiency by a gene chip among Chinese Hakka of southern Jiangxi province[J]. Int J Clin Exp Pathol, 2015, 8(11): 15013-15018.
[14]
赵振东,黄慈丹,许海珠,等. 海南省380 996名新生儿苯丙酮尿症筛查及苯丙氨酸羟化酶基因分析[J].中华医学杂志2020, 100(26): 2054-2058. DOI: 10.3760/cma.j.cn112137-20200120-00134.
[15]
Chen L, Zhang C, Wang Y, et al. Data mining and pathway analysis of glucose-6-phosphate dehydrogenase with natural language processing[J]. Mol Med Rep, 2017, 16(2): 1900-1910. DOI: 10.3892/mmr.2017.6785.
[16]
Zhang L, Yang Y, Liu R, et al. A multiplex method for detection of glucose-6-phosphate dehydrogenase (G6PD) gene mutations[J]. Int J Lab Hematol, 2015, 37(6): 739-745. DOI: 10.1111/ijlh.12405.
[17]
国家卫生健康委临床检验中心新生儿疾病筛查室间质评专家委员会. 新生儿葡萄糖-6-磷酸脱氢酶缺乏症筛查与诊断实验室检测技术专家共识[J]. 中华检验医学杂志2019, 42(3): 181-185. DOI: 10.3760/cma.j.issn.1009-9158.2019.03.007.
[18]
赵振东,王洁. 海南省新生儿葡萄糖-6-磷酸脱氢酶缺乏症发生情况及基因突变分析研究[J]. 中国全科医学2020, 23(6): 688-691, 698. DOI: 10.12114/j.issn.1007-9572.2019.00.612.
[19]
彭瑛,詹小亭,邓正华,等. 中国西南三区216例儿童葡萄糖-6-磷酸脱氢酶缺乏症基因型分布和临床特征分析[J]. 广东医学2019, 40(13): 1856-1860. DOI: 10.13820/j.cnki.gdyx.20186000.
[20]
Plewes K, Soontarawirat I, Ghose A, et al. Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria[J]. Malar J, 2017, 16(1): 134. DOI: 10.1186/s12936-017-1788-x.
[21]
Kalnoky M, Bancone G, Kahn M, et al. Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression[J]. Eur J Haematol, 2018, 100(3): 294-303. DOI: 10.1111/ejh.13013.
[22]
詹小芬,张芹,周露,等. 云南省西双版纳州傣族G6PD缺陷症发生率及突变谱研究[J]. 分子诊断与治疗杂志2015, 7(2): 83-86. DOI: 10.3969/j.issn.1674-6929.2015.02.003.
[23]
Sirdah M, Reading NS, Perkins SL, et al. Hemolysis and Mediterranean G6PD mutation (c.563 C>T) and c. 1311 C>T polymorphism among Palestinians at Gaza Strip[J]. Blood Cells Mol Dis, 2012, 48(4): 203-208. DOI: 10.1016/j.bcmd.2012.01.007.
[1] 林昌盛, 战军, 肖雪. 上皮性卵巢癌患者诊疗中基因检测及分子靶向药物治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 505-510.
[2] 罗丹, 孔为民, 陈姝宁, 赵小玲, 谢云凯. 子宫内膜异位症患者在位及异位内膜上皮细胞-间充质转化相关生物标志物的变化[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 530-539.
[3] 陈甜甜, 王晓东, 余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 559-568.
[4] 董晓燕, 赵琪, 唐军, 张莉, 杨晓燕, 李姣. 奥密克戎变异株感染所致新型冠状病毒感染疾病新生儿的临床特征分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 595-603.
[5] 李维, 莫俊俏. 儿童呼吸道耐药流感嗜血杆菌基因型鉴定及耐药分析对抗菌药物治疗选择的意义[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 315-323.
[6] 张小曼, 马筱秋, 许正锯, 张纯瑜, 何彩婷. 乙型肝炎病毒逆转录酶区耐药突变对血清乙型肝炎病毒表面抗原水平的影响[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 324-332.
[7] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[8] 樊丽超, 郭瑾瑛, 陈鑫. 野生型RET与RET/PTC融合基因检测对甲状腺乳头状癌中央区淋巴结清扫的指导意义[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 631-635.
[9] 袁育韬, 邢金琳, 谢克飞, 殷凯. CT征象及BRAFV600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 611-614.
[10] 彭雨诗, 苗芸, 严紫嫣. 宏基因组高通量测序诊断肾移植术后华支睾吸虫感染一例[J]. 中华移植杂志(电子版), 2023, 17(05): 297-299.
[11] 许丁伟, 马江云, 李新成, 黄洁. Alagille综合征疑诊为先天性胆道闭锁一例并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 681-687.
[12] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[13] 王飞飞, 王光林, 孟泽松, 李保坤, 曹龙飞, 张娟, 周超熙, 丁源一, 王贵英. 敲低IMPDH1对结肠癌SW480、HT29细胞生物功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(08): 884-890.
[14] 高红琴, 陈晨, 陆瑞科, 王小雨, 张敏, 李少华, 郝梨岚, 黄新程, 关凌耀, 张韵红. 外阴阴道假丝酵母菌病对女性阴道-宫颈菌群的影响研究[J]. 中华临床医师杂志(电子版), 2023, 17(06): 720-725.
[15] 张许平, 刘佳成, 张舸, 杜艳姣, 李韶, 商丹丹, 王浩, 李艳, 段智慧. CYP2C19基因多态性联合血栓弹力图指导大动脉粥样硬化型非致残性缺血性脑血管事件患者抗血小板治疗的效果[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 477-481.
阅读次数
全文


摘要